Cargando…
Human Monoclonal Antibody HCV1 Effectively Prevents and Treats HCV Infection in Chimpanzees
Hepatitis C virus (HCV) infection is a leading cause of liver transplantation and there is an urgent need to develop therapies to reduce rates of HCV infection of transplanted livers. Approved therapeutics for HCV are poorly tolerated and are of limited efficacy in this patient population. Human mon...
Autores principales: | Morin, Trevor J., Broering, Teresa J., Leav, Brett A., Blair, Barbra M., Rowley, Kirk J., Boucher, Elisabeth N., Wang, Yang, Cheslock, Peter S., Knauber, Michael, Olsen, David B., Ludmerer, Steve W., Szabo, Gyongyi, Finberg, Robert W., Purcell, Robert H., Lanford, Robert E., Ambrosino, Donna M., Molrine, Deborah C., Babcock, Gregory J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431327/ https://www.ncbi.nlm.nih.gov/pubmed/22952447 http://dx.doi.org/10.1371/journal.ppat.1002895 |
Ejemplares similares
-
High-Throughput Sequencing Analysis of Post-Liver Transplantation HCV E2 Glycoprotein Evolution in the Presence and Absence of Neutralizing Monoclonal Antibody
por: Babcock, Gregory J., et al.
Publicado: (2014) -
HCV-Specific T Cell Responses During and After Chronic HCV Infection
por: Luxenburger, Hendrik, et al.
Publicado: (2018) -
Priming persistence of HCV
por: Schuch, Anita, et al.
Publicado: (2015) -
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014) -
HCV Extrahepatic Manifestations
por: Kuna, Lucija, et al.
Publicado: (2019)